Why the government’s renewed interest in peptides excludes this one.

THE TRUMP ADMINISTRATION has not been shy about its pro-peptide stance. US Health and Human Services Secretary Robert F. Kennedy Jr. has pushed to make six popular yet unapproved peptides available for compounding to people with a prescription. A recent FDA advisory committee meeting voted in favor of adding six out of seven peptides to a list of substances that U.S. compounding pharmacies are allowed to manufacture and supply.

Six out of seven. So what happened to that last peptide? Emideltide, also dubbed DSIP, is a peptide people have turned to for better sleep. And it was…

Read the full article at MENSHEALTH.COM